60 Degrees Pharmaceuticals Inc banner
6

60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP

Watchlist Manager
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Watchlist
Price: 4.16 USD 8.05%
Market Cap: $4.4m

Relative Value

The Relative Value of one SXTP stock under the Base Case scenario is hidden USD. Compared to the current market price of 4.16 USD, 60 Degrees Pharmaceuticals Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SXTP Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

SXTP Competitors Multiples
60 Degrees Pharmaceuticals Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
4.4m USD 3.2 -0.5 -0.1 -0.1
US
Eli Lilly and Co
NYSE:LLY
997.2B USD 15.7 49.5 33.3 35.4
US
Johnson & Johnson
NYSE:JNJ
578.6B USD 6.1 21.5 15 18.4
CH
Roche Holding AG
SIX:ROG
281.8B CHF 4.6 30.2 12.7 14.9
US
Merck & Co Inc
NYSE:MRK
303.5B USD 4.7 16.6 10.4 12.1
CH
Novartis AG
SIX:NOVN
231.3B CHF 5.3 21.3 13.1 16.9
UK
AstraZeneca PLC
LSE:AZN
218.1B GBP 5.2 32.1 15.3 22.4
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK 4.5 13.6 10 11.7
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 333.1 835.4
US
Pfizer Inc
NYSE:PFE
154.7B USD 2.5 19.9 7.4 9.9
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD 2.6 17.9 7 8.9
P/E Multiple
Earnings Growth PEG
US
6
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Average P/E: 24.7
Negative Multiple: -0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
49.5
28%
1.8
US
Johnson & Johnson
NYSE:JNJ
21.5
7%
3.1
CH
Roche Holding AG
SIX:ROG
30.2
29%
1
US
Merck & Co Inc
NYSE:MRK
16.6
14%
1.2
CH
Novartis AG
SIX:NOVN
21.3
15%
1.4
UK
AstraZeneca PLC
LSE:AZN
32.1
38%
0.8
DK
Novo Nordisk A/S
CSE:NOVO B
13.6
7%
1.9
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
US
Pfizer Inc
NYSE:PFE
19.9
26%
0.8
US
Bristol-Myers Squibb Co
NYSE:BMY
17.9
17%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
6
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Average EV/EBITDA: 45.7
Negative Multiple: -0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
33.3
18%
1.9
US
Johnson & Johnson
NYSE:JNJ
15
2%
7.5
CH
Roche Holding AG
SIX:ROG
12.7
5%
2.5
US
Merck & Co Inc
NYSE:MRK
10.4
7%
1.5
CH
Novartis AG
SIX:NOVN
13.1
9%
1.5
UK
AstraZeneca PLC
LSE:AZN
15.3
10%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
10
7%
1.4
IE
E
Endo International PLC
LSE:0Y5F
333.1
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.4
-4%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7
-13%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
6
60 Degrees Pharmaceuticals Inc
NASDAQ:SXTP
Average EV/EBIT: 98.6
Negative Multiple: -0.1
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.4
17%
2.1
US
Johnson & Johnson
NYSE:JNJ
18.4
6%
3.1
CH
Roche Holding AG
SIX:ROG
14.9
6%
2.5
US
Merck & Co Inc
NYSE:MRK
12.1
6%
2
CH
Novartis AG
SIX:NOVN
16.9
12%
1.4
UK
AstraZeneca PLC
LSE:AZN
22.4
23%
1
DK
Novo Nordisk A/S
CSE:NOVO B
11.7
8%
1.5
IE
E
Endo International PLC
LSE:0Y5F
835.4
N/A N/A
US
Pfizer Inc
NYSE:PFE
9.9
-1%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
8.9
-6%
N/A